Dario LEHOUX,Thomas R. PARR,Gregory MOECK,Pierre ETIENNE
申请号：
US13763799
公开号：
US20130172237A1
申请日:
2013.02.11
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Glycopeptide antibiotics, such as oritavancin, demonstrate significant activity against a wide range of bacteria. Methods for the treatment, prophylaxis and prevention of bacterial infection and disease in animals, including humans, using a single dose of oritavancin over the course of therapy, are described.
